Whole genome sequencing of healthy donor CD34+ cells incubated with sEVs from MDS-derived MSCs showed that sEVs from MDS-derived MSCs are able to induce a mutational signature found in cancers listed in the COSMIC cancer database (https://cancer.sanger.ac.uk/cosmic, accessed on 25 December 2022). The gene discussed is CD34; the disease is cancer.